183 related articles for article (PubMed ID: 11404115)
1. Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis.
van der Meulen MF; Hoogendijk JE; Moons KG; Veldman H; Badrising UA; Wokke JH
Neuromuscul Disord; 2001 Jul; 11(5):447-51. PubMed ID: 11404115
[TBL] [Abstract][Full Text] [Related]
2. Absence of characteristic features in two patients with inclusion body myositis.
van der Meulen MF; Hoogendijk JE; Jansen GH; Veldman H; Wokke JH
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):396-8. PubMed ID: 9527159
[TBL] [Abstract][Full Text] [Related]
3. Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled.
van de Vlekkert J; Hoogendijk JE; de Visser M
Neuromuscul Disord; 2015 Jun; 25(6):451-6. PubMed ID: 25817837
[TBL] [Abstract][Full Text] [Related]
4. Inclusion body myositis: morphological clues to correct diagnosis.
Dahlbom K; Lindberg C; Oldfors A
Neuromuscul Disord; 2002 Nov; 12(9):853-7. PubMed ID: 12398837
[TBL] [Abstract][Full Text] [Related]
5. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis.
Girolamo F; Lia A; Amati A; Strippoli M; Coppola C; Virgintino D; Roncali L; Toscano A; Serlenga L; Trojano M
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):736-49. PubMed ID: 23452291
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis.
Prayson RA; Cohen ML
Hum Pathol; 1997 Aug; 28(8):887-92. PubMed ID: 9269823
[TBL] [Abstract][Full Text] [Related]
8. Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis.
Semino-Mora C; Dalakas MC
Hum Pathol; 1998 Oct; 29(10):1128-33. PubMed ID: 9781653
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of manganese superoxide dismutase is associated with that of nitrotyrosine in myopathies with rimmed vacuoles.
Tsuruta Y; Furuta A; Taniguchi N; Yamada T; Kira J; Iwaki T
Acta Neuropathol; 2002 Jan; 103(1):59-65. PubMed ID: 11837748
[TBL] [Abstract][Full Text] [Related]
10. Inclusion body myositis: atypical clinical presentations.
Schlesinger I; Soffer D; Lossos A; Meiner Z; Argov Z
Eur Neurol; 1996; 36(2):89-93. PubMed ID: 8654492
[TBL] [Abstract][Full Text] [Related]
11. Amyloid filaments in inclusion body myositis. Novel findings provide insight into nature of filaments.
Mendell JR; Sahenk Z; Gales T; Paul L
Arch Neurol; 1991 Dec; 48(12):1229-34. PubMed ID: 1668977
[TBL] [Abstract][Full Text] [Related]
12. Expression of the lysosome-associated membrane proteins in myopathies with rimmed vacuoles.
Tsuruta Y; Furuta A; Furuta K; Yamada T; Kira J; Iwaki T
Acta Neuropathol; 2001 Jun; 101(6):579-84. PubMed ID: 11515786
[TBL] [Abstract][Full Text] [Related]
13. Nuclear membrane proteins are present within rimmed vacuoles in inclusion-body myositis.
Greenberg SA; Pinkus JL; Amato AA
Muscle Nerve; 2006 Oct; 34(4):406-16. PubMed ID: 16823856
[TBL] [Abstract][Full Text] [Related]
14. Congenital myopathy with abundant ring fibres, rimmed vacuoles and inclusion body myositis-type inclusions.
Fidziańska A; Kamińska A
Neuropediatrics; 2003 Feb; 34(1):40-4. PubMed ID: 12690567
[TBL] [Abstract][Full Text] [Related]
15. An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families.
Sivakumar K; Semino-Mora C; Dalakas MC
Brain; 1997 Apr; 120 ( Pt 4)():653-61. PubMed ID: 9153127
[TBL] [Abstract][Full Text] [Related]
16. The prion protein in human neuromuscular diseases.
Kovács GG; Kalev O; Gelpi E; Haberler C; Wanschitz J; Strohschneider M; Molnár MJ; László L; Budka H
J Pathol; 2004 Nov; 204(3):241-7. PubMed ID: 15476279
[TBL] [Abstract][Full Text] [Related]
17. A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis.
Brady S; Squier W; Sewry C; Hanna M; Hilton-Jones D; Holton JL
BMJ Open; 2014 Apr; 4(4):e004552. PubMed ID: 24776709
[TBL] [Abstract][Full Text] [Related]
18. Inclusion body myositis--a review.
Vogel H
Adv Anat Pathol; 1998 May; 5(3):164-9. PubMed ID: 9868522
[TBL] [Abstract][Full Text] [Related]
19. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
Maurage CA; Bussière T; Sergeant N; Ghesteem A; Figarella-Branger D; Ruchoux MM; Pellissier JF; Delacourte A
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):624-34. PubMed ID: 15541003
[TBL] [Abstract][Full Text] [Related]
20. Inclusion body myositis (IBM).
Gayathri N; Anisya-Vasanth ; Veerendra Kumar M; Das S; Santosh V; Yasha TC; Ramamohan Y; Taly AB; Gourie-Devi M; Shankar SK
Clin Neuropathol; 2000; 19(1):13-20. PubMed ID: 10774946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
